<\/p>\n
Kenacort injekci\u00f3<\/strong> is a sterile depot suspension from Abbott Healthcare containing triamcinolone acetonide<\/strong> itt 10 mg\/mL and 40 mg\/mL vials<\/strong>, supplied for intramuscular (IM) or intra-articular (IA) injection<\/strong>. Triamcinolone acetonide is highly insoluble — once injected it forms a microcrystalline depot that releases active drug slowly over 2–6 weeks<\/strong>, giving prolonged anti-inflammatory effect from a single injection. Common uses: intra-articular injection<\/strong> for knee, shoulder and small-joint inflammation in osteoarthritis or rheumatoid arthritis; intramuscular depot<\/strong> for severe seasonal allergic rhinitis, dermatologic flares, asthma exacerbations not requiring hospitalisation; intralesional injection<\/strong> for hypertrophic scars, keloids, alopecia areata, localised psoriasis. Joint-injection limits<\/strong>: no more than 3–4 injections per joint per year<\/strong>, no more than one injection every 3 months<\/strong> per joint — more frequent use accelerates cartilage damage. Local side effects include skin atrophy and depigmentation around the injection site, fat atrophy at IM sites, post-injection joint flare, and (rarely) septic arthritis. Systemic effects mimic oral steroids in proportion to the cumulative dose absorbed.<\/p>\n<\/div>\n <\/p>\n \ud83d\udce6 Minden rendel\u00e9st fedez a \u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n Generikus gy\u00f3gyszereink WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3kt\u00f3l sz\u00e1rmaznak, \u00e9s diszkr\u00e9t, egyszer\u0171 csomagol\u00e1sban sz\u00e1ll\u00edtjuk \u0151ket vil\u00e1gszerte \u2014 a csomagon nem szerepel a gy\u00f3gyszer neve. A k\u00e1rty\u00e1s fizet\u00e9sek egy szab\u00e1lyozott feldolgoz\u00f3n kereszt\u00fcl t\u00f6rt\u00e9nnek (a sz\u00e1mlale\u00edr\u00e1sok egy szab\u00e1lyozott k\u00e1rtyafizet\u00e9si feldolgoz\u00f3t tartalmaznak \u2014 soha nem \u201cMedsBase\u201d vagy b\u00e1rmilyen gy\u00f3gyszer neve). Kriptovalut\u00e1t \u00e9s SEPA banki \u00e1tutal\u00e1st is elfogadunk. Minden rendel\u00e9st a Reshipment Assurance Policy biztos\u00edt\u00e9k fedez.<\/p>\n Kenacort Injection is a depot suspension for intramuscular and intra-articular injection manufactured by Abbott Healthcare containing triamcinolone acetonide<\/strong> \u2014 szintetikus kortikoszteroid a gl\u00fckokortikoid oszt\u00e1lyban. A gl\u00fckokortikoidok a leger\u0151sebb sz\u00e9les spektrum\u00fa gyullad\u00e1scs\u00f6kkent\u0151 \u00e9s immunszuppressz\u00edv gy\u00f3gyszerek, szinte minden sz\u00f6vetben \u00e9s szervrendszerben hat\u00e1ssal vannak.<\/p>\n Kenacort Injection is the original Indian-market injectable triamcinolone acetonide depot from Abbott Healthcare. The 10 mg\/mL strength<\/strong> is used for small-joint intra-articular injection and intralesional dermatology (alopecia, scars). The 40 mg\/mL strength<\/strong> is used for intramuscular depot, large-joint intra-articular (knee, shoulder) and high-dose intralesional treatment of keloid scars.<\/p>\n Triamcinolone 4 mg is approximately equivalent to prednisolone 5 mg (potency ratio ~5). The physiological daily cortisol output of a healthy adult is approximately 5–7.5 mg of prednisolone-equivalent — any dose above that is “supraphysiological” and begins to suppress the hypothalamic-pituitary-adrenal (HPA) axis.<\/p>\n Why a depot suspension?<\/strong> Triamcinolone acetonide is far less water-soluble than the sodium-phosphate or sodium-succinate esters used for IV steroids. Once injected, it forms microscopic crystals that dissolve over weeks, providing sustained low-dose glucocorticoid release without the daily-dosing burden of oral therapy. This is ideal for joint inflammation (where an injection inside the joint capsule keeps the drug locally concentrated), severe seasonal allergy (one IM injection covers most of the pollen season), and dermatology (localised intralesional injection of keloids, alopecia patches, hypertrophic scars).<\/p>\n Triamcinolone enters cells, binds the intracellul\u00e1ris gl\u00fckokortikoid receptorhoz<\/strong>, \u00e9s a receptor-gy\u00f3gyszer komplex a sejtmagba v\u00e1ndorol, ahol sz\u00e1zak g\u00e9nj\u00e9nek transzkripci\u00f3j\u00e1t m\u00f3dos\u00edtja. A v\u00e9geredm\u00e9ny a gyullad\u00e1sos kask\u00e1d sz\u00e9les k\u00f6r\u0171 csillap\u00edt\u00e1sa:<\/p>\n Clinical onset (depot IM\/IA): noticeable improvement within 24\u201348 \u00f3r\u00e1n<\/strong> for joint inflammation; peak effect at 7–14 days. Total duration of useful effect: 2–6 weeks<\/strong> (joint), 3\u20136 h\u00e9tig is eltarthat<\/strong> (IM depot for allergic rhinitis), 2–3 months<\/strong> (intralesional in keloid scars).<\/p>\n Kenacort Injection is used wherever sustained local or systemic glucocorticoid effect is wanted from a single injection.<\/p>\n Kenacort Injection is nem<\/strong> appropriate for: routine first-line management of osteoarthritis (lifestyle, weight, physiotherapy and NSAIDs first), septic arthritis (steroid is contraindicated until infection cleared), spinal injection (has been associated with rare but devastating cord infarction — best avoided in favour of soluble preparations), or any joint that has been injected within the past 3 months.<\/p>\n Kenacort Injection is supplied at 10 mg\/mL and 40 mg\/mL vials<\/strong>. Dose depends entirely on the indication and the route — this is a specialist or trained-clinician procedure<\/strong>, not for self-administration.<\/p>\nMi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n
What Is Kenacort Injection?<\/h2>\n
How Does Kenacort Injection Work?<\/h2>\n
\n
Felhaszn\u00e1l\u00e1s \u00e9s indik\u00e1ci\u00f3k<\/h2>\n
Intra-articular (IA) injection — into a joint<\/h3>\n
\n
Intramuscular (IM) depot — gluteal injection<\/h3>\n
\n
Intralesional injection — into the lesion<\/h3>\n
\n
Kenacort Injection Dosage and How to Use<\/h2>\n
Typical adult doses by route and indication<\/h3>\n